Future Directions and Pipeline Therapies for Hidradenitis Suppurativa
Dermatologic Clinics · 2025
DOI: 10.1016/j.det.2024.12.016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Dermatologic Clinics, 2025. Verfasst von Kim T Nguyen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Minnesota, Minneapolis, MN, USA; College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Dermatologic Agents. Die Arbeit nennt 79 Literaturangaben.
Abstract (Originalsprache)
Hidradenitis suppurativa (HS) is a painful, autoinflammatory condition with dramaticimpact on quality of life. As of January 1, 2024, there are 25 phase I-III clinical trials for topical and systematic medications in the management of HS. Only three medications, adalimumab, secukinumab and bemikizumab, are currently approved by the United States Food and Drug Administration for the treatment of moderate to severe HS. In addition, 15 nonmedication-based studies are ongoing, including those for various surgical techniques, botulinum toxin, laser and light-based therapies, differing wound care methods, and a variety of complementary and alternative medicine practices for HS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Minnesota, Minneapolis, MN, USA; College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
- Georgetown University School of Medicine, Washington, DC, USA.
- Department of Dermatology, University of Minnesota, Minneapolis, MN, USA; Department of Medicine, University of Minnesota, Minneapolis, MN, USA; Departments of Medicine and Dermatology, Minneapolis Veteran Affairs Healt…
Zitieren
APA
Nguyen, K. T., Jaguan, D., & Goldfarb, N. (2025). Future Directions and Pipeline Therapies for Hidradenitis Suppurativa. Dermatologic Clinics. https://doi.org/10.1016/j.det.2024.12.016
Vancouver
Nguyen KT, Jaguan D, Goldfarb N. Future Directions and Pipeline Therapies for Hidradenitis Suppurativa. Dermatologic Clinics. 2025. doi:10.1016/j.det.2024.12.016
BibTeX
@article{Nguyen2025,
author = {Nguyen, Kim T and Jaguan, Daniella and Goldfarb, Noah},
title = {Future Directions and Pipeline Therapies for Hidradenitis Suppurativa},
journal = {Dermatologic Clinics},
year = {2025},
doi = {10.1016/j.det.2024.12.016}
}
EUVIMED